Leerink Swann reiterated their outperform rating on shares of Walgreens Boots Alliance Inc. (NASDAQ:WBA) in a research note issued to investors on Monday morning. They currently have a $95.00 target price on the pharmacy operator’s stock.

WBA has been the subject of a number of other reports. Robert W. Baird reaffirmed an outperform rating and issued a $98.00 price target on shares of Walgreens Boots Alliance in a research note on Monday, June 27th. Evercore ISI reaffirmed a buy rating and issued a $93.00 price target on shares of Walgreens Boots Alliance in a research note on Thursday, July 7th. Zacks Investment Research raised Walgreens Boots Alliance from a sell rating to a hold rating in a research note on Tuesday, June 21st. Credit Suisse Group AG reaffirmed an outperform rating and issued a $95.00 price target (up from $80.71) on shares of Walgreens Boots Alliance in a research note on Thursday, September 1st. Finally, Deutsche Bank AG reaffirmed a buy rating on shares of Walgreens Boots Alliance in a research note on Monday, July 18th. One analyst has rated the stock with a sell rating, five have given a hold rating and fifteen have given a buy rating to the company’s stock. The company currently has an average rating of Buy and an average price target of $93.13.

Shares of Walgreens Boots Alliance (NASDAQ:WBA) opened at 82.38 on Monday. The firm has a 50-day moving average of $81.79 and a 200-day moving average of $81.27. Walgreens Boots Alliance has a 1-year low of $71.50 and a 1-year high of $95.74. The firm has a market capitalization of $89.16 billion, a PE ratio of 28.47 and a beta of 1.01.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings results on Wednesday, July 6th. The pharmacy operator reported $1.18 EPS for the quarter, beating analysts’ consensus estimates of $1.14 by $0.04. The company earned $29.50 billion during the quarter. Walgreens Boots Alliance had a return on equity of 15.56% and a net margin of 2.70%. The business’s revenue was up 2.4% compared to the same quarter last year. During the same period last year, the company earned $1.02 earnings per share. On average, equities research analysts anticipate that Walgreens Boots Alliance will post $4.51 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which was paid on Monday, September 12th. Shareholders of record on Friday, August 19th were issued a dividend of $0.375 per share. This is an increase from Walgreens Boots Alliance’s previous quarterly dividend of $0.36. The ex-dividend date was Wednesday, August 17th. This represents a $1.50 annualized dividend and a yield of 1.82%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is currently 51.90%.

In other Walgreens Boots Alliance news, Director William C. Foote sold 2,067 shares of the stock in a transaction on Tuesday, July 26th. The stock was sold at an average price of $81.35, for a total transaction of $168,150.45. Following the transaction, the director now owns 26,690 shares in the company, valued at approximately $2,171,231.50. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Kathleen Wilson-Thompson sold 29,695 shares of the stock in a transaction on Thursday, July 14th. The stock was sold at an average price of $83.00, for a total value of $2,464,685.00. The disclosure for this sale can be found here. Company insiders own 21.10% of the company’s stock.

A number of hedge funds and other institutional investors have recently bought and sold shares of the company. CapWealth Advisors LLC boosted its position in Walgreens Boots Alliance by 30.0% in the first quarter. CapWealth Advisors LLC now owns 1,300 shares of the pharmacy operator’s stock valued at $110,000 after buying an additional 300 shares during the last quarter. Kings Point Capital Management boosted its position in shares of Walgreens Boots Alliance by 12.8% in the first quarter. Kings Point Capital Management now owns 1,323 shares of the pharmacy operator’s stock worth $111,000 after buying an additional 150 shares during the last quarter. Jolley Asset Management LLC boosted its position in shares of Walgreens Boots Alliance by 104.5% in the second quarter. Jolley Asset Management LLC now owns 1,370 shares of the pharmacy operator’s stock worth $114,000 after buying an additional 700 shares during the last quarter. MCF Advisors LLC boosted its position in shares of Walgreens Boots Alliance by 0.4% in the first quarter. MCF Advisors LLC now owns 1,371 shares of the pharmacy operator’s stock worth $116,000 after buying an additional 6 shares during the last quarter. Finally, Westbourne Investment Advisors Inc. bought a new position in shares of Walgreens Boots Alliance during the second quarter worth approximately $121,000. Hedge funds and other institutional investors own 59.74% of the company’s stock.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

5 Day Chart for NASDAQ:WBA

Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with MarketBeat.com's FREE daily email newsletter.